Apimeds Pharmaceuticals US, Inc. (APUS) vs Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Apimeds Pharmaceuticals US, Inc. and Shuttle Pharmaceuticals Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Shuttle Pharmaceuticals Holdings, Inc. is the larger, with a market value of $15.6M against $7.6M — 2.1× the size. Apimeds Pharmaceuticals US, Inc. has negative trailing earnings, so its P/E is not meaningful; Shuttle Pharmaceuticals Holdings, Inc. trades at 34.7×. Across the 10 metrics below, Apimeds Pharmaceuticals US, Inc. leads on 6 and Shuttle Pharmaceuticals Holdings, Inc. on 4.
Valuation
Profitability
| Metric | APUS | SHPH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | — | 0.00% | 53.94% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (100.13%) | (326.36%) | (0.40%) |
| Return on assets | (84.20%) | (126.42%) | (3.32%) |
| Return on invested capital | (15.96%) | (309.75%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack